Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis.

Author:

Peck-Radosavljevic Markus1,Kudo Masatoshi2,Raoul Jean-Luc3,Lee Han Chu4,Decaens Thomas5,Heo Jeong6,Lin Shi-Ming7,Shan Hong8,Yang Yefa9,Bayh Inga10,Nakajima Keiko11,Cheng Ann-Lii12

Affiliation:

1. Medical University of Vienna/ Klinikum Klagenfurt am Wörthersee, Vienna/Klagenfurt, Austria;

2. Kindai University Faculty of Medicine, Osaka, Japan;

3. Digestive Oncology, Institut de Cancérologie de l’Ouest, Nantes, France;

4. Asan Medical Center, Seoul, Korea, Republic of (South);

5. Clinique Universitaire d'Hépato-gastroentérologie, CHU Grenoble Alpes, Grenoble, France;

6. College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Korea, Republic of (South);

7. Chang Gung Memorial Hospital, Taipei, Taiwan;

8. Department of Radiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China;

9. Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China;

10. Bayer AG, SBU Oncology, Pharmaceuticals, Wuppertal, Germany;

11. Bayer HealthCare Pharmaceuticals, Whippany, NJ;

12. National Taiwan University Hospital, Taipei, Taiwan;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3